- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer ; volume:199 ; number:6 ; day:17 ; month:3 ; year:2023 ; pages:574-584 ; date:6.2023
Strahlentherapie und Onkologie ; 199, Heft 6 (17.3.2023), 574-584, 6.2023
- Urheber
-
Rosenbrock, Johannes
Baues, Christian
Kreis, Marius
Fouassi, Redouane
Celik, Eren
Paffenholz, Pia
Pfister, David
Heidenreich, Axel
Marnitz, Simone
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00066-023-02060-2
- URN
-
urn:nbn:de:101:1-2023091013181485215596
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rosenbrock, Johannes
- Baues, Christian
- Kreis, Marius
- Fouassi, Redouane
- Celik, Eren
- Paffenholz, Pia
- Pfister, David
- Heidenreich, Axel
- Marnitz, Simone
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dose-volume analysis of predictors for acute anal toxicity after radiotherapy in prostate cancer patients
Radiotherapy-induced toxicity in prostate cancer patients with hip prostheses
Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial
Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?
Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
Image guided dose escalated prostate radiotherapy: still room to improve
Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial
Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy
Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis
Prostate radiotherapy may cause fertility issues: a retrospective analysis of testicular dose following modern radiotherapy techniques
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
Dose-volume analysis of predictors for acute anal toxicity after radiotherapy in prostate cancer patients
Radiotherapy-induced toxicity in prostate cancer patients with hip prostheses
Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial
Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?
Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
Image guided dose escalated prostate radiotherapy: still room to improve
Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial
Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy
Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis
Prostate radiotherapy may cause fertility issues: a retrospective analysis of testicular dose following modern radiotherapy techniques
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
Dose-volume analysis of predictors for acute anal toxicity after radiotherapy in prostate cancer patients
Radiotherapy-induced toxicity in prostate cancer patients with hip prostheses
Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial
Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?
Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
Image guided dose escalated prostate radiotherapy: still room to improve
Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial
Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy
Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis
Prostate radiotherapy may cause fertility issues: a retrospective analysis of testicular dose following modern radiotherapy techniques
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis